Determination of chemically reduced pyrrolobenzodiazepine SJG-136 in human plasma by HPLC-MS/MS: application to an anticancer phase I dose escalation study

2007 ◽  
Vol 43 (1) ◽  
pp. 42-52 ◽  
Author(s):  
M. Wade Calcutt ◽  
Wooin Lee ◽  
Igor Puzanov ◽  
Mace L. Rothenberg ◽  
David L. Hachey
Keyword(s):  
Phase I ◽  
Human Plasma ◽  
Dose Escalation ◽  
Dose Escalation Study

scholarly journals Phase I/II Intra-patient Dose Escalation Study of Vorinostat in Children with Relapsed Solid Tumor, Lymphoma or Leukemia

2012 ◽  
Vol 224 (06) ◽  
pp. 398-403 ◽  
Author(s):  
O. Witt ◽  
T. Milde ◽  
H. Deubzer ◽  
I. Oehme ◽  
R. Witt ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Solid Tumor ◽  
Patient Dose ◽  
Dose Escalation Study

scholarly journals IMCT-10A PHASE I DOSE ESCALATION STUDY TO TEST THE SAFETY OF INTRATUMORAL ADOPTIVE IMMUNE THERAPY WITH AlloCTL IN RECURRENT GLIOMA PATIENTS

2015 ◽  
Vol 17 (suppl 5) ◽  
pp. v109.3-v109 ◽  
Author(s):  
Michelle Hickey ◽  
Horacio Soto ◽  
Janet Treger ◽  
Kate Erickson ◽  
Colin Malone ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Immune Therapy ◽  
Recurrent Glioma ◽  
Dose Escalation Study

scholarly journals Phase I Dose‐Escalation Study of Pilaralisib (SAR245408, XL147) in Combination with Paclitaxel and Carboplatin in Patients with Solid Tumors

2017 ◽  
Vol 22 (4) ◽  
pp. 377 ◽  
Author(s):  
Jennifer Wheler ◽  
David Mutch ◽  
Joanne Lager ◽  
Christelle Castell ◽  
Li Liu ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Dose Escalation Study

1246 POSTER A Phase I Dose-escalation Study of EMD 1214063, an Oral Selective C-Met Inhibitor, in Patients With Advanced Solid Tumours

2011 ◽  
Vol 47 ◽  
pp. S158
Author(s):  
G.S. Falchook ◽  
S. Fu ◽  
H.M. Amin ◽  
S.A. Piha-Paul ◽  
D.S. Hong ◽  
...  
Keyword(s):  
Phase I ◽  
Dose Escalation ◽  
Solid Tumours ◽  
Dose Escalation Study ◽  
Met Inhibitor
Sign in / Sign up

Export Citation Format

Share Document